HomeGeneticsConditionHereditary sensory neuropathy type IA
Back to Condition
Hereditary sensory neuropathy type IA
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Hereditary sensory neuropathy type IA

Hereditary sensory neuropathy type IA is a progressive condition characterized by nerve abnormalities in the legs and feet, leading to loss of sensation, muscle weakness, and a risk of slow-healing ulcers.

Overview

Hereditary sensory neuropathy type IA (HSAN IA) involves the gradual destruction of neurons. Symptoms typically emerge between adolescence and late adulthood and worsen over time, though life expectancy is generally normal with proper management.

Symptoms

  • Sensory loss: Tingling (paresthesias), numbness, and a reduced ability to feel pain, heat, or cold in the legs and feet. Some individuals experience shooting pains.
  • Physical complications: Open sores (ulcers) on the feet or hands and infections of the fingertips (whitlows). Because of reduced pain sensation, these are often slow to heal and may lead to amputation if untreated.
  • Muscle weakness: Muscle wasting and weakness, particularly in the ankles, which may eventually require wheelchair assistance.
  • Hearing loss: Sensorineural hearing loss may develop in middle to late adulthood.

Causes & Risk Factors

Mutations in the SPTLC1 gene cause this condition. This gene provides instructions for the serine palmitoyltransferase (SPT) enzyme. Mutations cause the enzyme to produce toxic deoxysphingoid bases, which accumulate and destroy nerve cells.

Inheritance

This condition is inherited in an autosomal dominant pattern, meaning one copy of the altered gene in each cell is sufficient to cause the disorder.

Frequently Asked Questions

Currently there is no disease‑modifying drug approved for HSAN IA. Management focuses on symptomatic care: pain modulators (e.g., gabapentin) for shooting pains, physical therapy to maintain strength, and strict foot protection. Research into serine supplementation is ongoing, but it remains investigational.
Inspect both feet every morning and evening using a mirror or a partner’s help; wash gently, keep skin moisturized (avoid between toes), trim nails straight, wear well‑fitting, cushioned shoes, and use custom orthotics to off‑load pressure points. Any small sore should be seen by a podiatrist within 24 hours.
targeted SPTLC1 gene test confirms the diagnosis. Once identified, offer predictive testing to first‑degree relatives with pre‑test counseling to discuss implications, inheritance (autosomal dominant), and options for early surveillance and lifestyle modifications.
Baseline audiometry should be performed at diagnosis and repeated every 2–3 years. If sensorineural loss is detected, hearing aids or cochlear implants (for severe cases) are effective. Regular ENT follow‑up is recommended to address balance or tinnitus issues.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA